Cargando…

P545: VENETOCLAX (VEN) COMBINED WITH FLAG-IDA IS AN EFFECTIVE REGIMEN FOR PATIENTS (PTS) WITH NEWLY DIAGNOSED (ND) AND RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML)

Detalles Bibliográficos
Autores principales: Burkart, Madelyn, Khan, Talha, Dinner, Shira, Frankfurt, Olga, Altman, Jessica, Abaza, Yasmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428945/
http://dx.doi.org/10.1097/01.HS9.0000969088.50486.31
_version_ 1785090592549634048
author Burkart, Madelyn
Khan, Talha
Dinner, Shira
Frankfurt, Olga
Altman, Jessica
Abaza, Yasmin
author_facet Burkart, Madelyn
Khan, Talha
Dinner, Shira
Frankfurt, Olga
Altman, Jessica
Abaza, Yasmin
author_sort Burkart, Madelyn
collection PubMed
description
format Online
Article
Text
id pubmed-10428945
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104289452023-08-17 P545: VENETOCLAX (VEN) COMBINED WITH FLAG-IDA IS AN EFFECTIVE REGIMEN FOR PATIENTS (PTS) WITH NEWLY DIAGNOSED (ND) AND RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML) Burkart, Madelyn Khan, Talha Dinner, Shira Frankfurt, Olga Altman, Jessica Abaza, Yasmin Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428945/ http://dx.doi.org/10.1097/01.HS9.0000969088.50486.31 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Burkart, Madelyn
Khan, Talha
Dinner, Shira
Frankfurt, Olga
Altman, Jessica
Abaza, Yasmin
P545: VENETOCLAX (VEN) COMBINED WITH FLAG-IDA IS AN EFFECTIVE REGIMEN FOR PATIENTS (PTS) WITH NEWLY DIAGNOSED (ND) AND RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML)
title P545: VENETOCLAX (VEN) COMBINED WITH FLAG-IDA IS AN EFFECTIVE REGIMEN FOR PATIENTS (PTS) WITH NEWLY DIAGNOSED (ND) AND RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML)
title_full P545: VENETOCLAX (VEN) COMBINED WITH FLAG-IDA IS AN EFFECTIVE REGIMEN FOR PATIENTS (PTS) WITH NEWLY DIAGNOSED (ND) AND RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML)
title_fullStr P545: VENETOCLAX (VEN) COMBINED WITH FLAG-IDA IS AN EFFECTIVE REGIMEN FOR PATIENTS (PTS) WITH NEWLY DIAGNOSED (ND) AND RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML)
title_full_unstemmed P545: VENETOCLAX (VEN) COMBINED WITH FLAG-IDA IS AN EFFECTIVE REGIMEN FOR PATIENTS (PTS) WITH NEWLY DIAGNOSED (ND) AND RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML)
title_short P545: VENETOCLAX (VEN) COMBINED WITH FLAG-IDA IS AN EFFECTIVE REGIMEN FOR PATIENTS (PTS) WITH NEWLY DIAGNOSED (ND) AND RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML)
title_sort p545: venetoclax (ven) combined with flag-ida is an effective regimen for patients (pts) with newly diagnosed (nd) and relapsed/refractory (r/r) acute myeloid leukemia (aml)
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428945/
http://dx.doi.org/10.1097/01.HS9.0000969088.50486.31
work_keys_str_mv AT burkartmadelyn p545venetoclaxvencombinedwithflagidaisaneffectiveregimenforpatientsptswithnewlydiagnosedndandrelapsedrefractoryrracutemyeloidleukemiaaml
AT khantalha p545venetoclaxvencombinedwithflagidaisaneffectiveregimenforpatientsptswithnewlydiagnosedndandrelapsedrefractoryrracutemyeloidleukemiaaml
AT dinnershira p545venetoclaxvencombinedwithflagidaisaneffectiveregimenforpatientsptswithnewlydiagnosedndandrelapsedrefractoryrracutemyeloidleukemiaaml
AT frankfurtolga p545venetoclaxvencombinedwithflagidaisaneffectiveregimenforpatientsptswithnewlydiagnosedndandrelapsedrefractoryrracutemyeloidleukemiaaml
AT altmanjessica p545venetoclaxvencombinedwithflagidaisaneffectiveregimenforpatientsptswithnewlydiagnosedndandrelapsedrefractoryrracutemyeloidleukemiaaml
AT abazayasmin p545venetoclaxvencombinedwithflagidaisaneffectiveregimenforpatientsptswithnewlydiagnosedndandrelapsedrefractoryrracutemyeloidleukemiaaml